Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Necrotizing encephalopathy, infantile subacute, of Leigh
0.300 Biomarker disease CLINGEN Succinyl-CoA synthetase (SUCLA2) deficiency in two siblings with impaired activity of other mitochondrial oxidative enzymes in skeletal muscle without mitochondrial DNA depletion. 27913098 2017
Necrotizing encephalopathy, infantile subacute, of Leigh
0.300 Biomarker disease CLINGEN Loss of succinyl-CoA synthase ADP-forming β subunit disrupts mtDNA stability and mitochondrial dynamics in neurons. 28769029 2017
Necrotizing encephalopathy, infantile subacute, of Leigh
0.300 Biomarker disease CLINGEN Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients. 26475597 2016
Necrotizing encephalopathy, infantile subacute, of Leigh
0.300 Biomarker disease CLINGEN Novel mutation in SUCLA2 identified on sequencing analysis. 26952923 2016
Necrotizing encephalopathy, infantile subacute, of Leigh
0.300 Biomarker disease CLINGEN Proteomics. Tissue-based map of the human proteome. 25613900 2015
Necrotizing encephalopathy, infantile subacute, of Leigh
0.300 Biomarker disease CLINGEN [SUCLA2-related encephalomyopathic mitochondrial DNA depletion syndrome: a case report and review of literature]. 25582465 2014
Necrotizing encephalopathy, infantile subacute, of Leigh
0.300 Biomarker disease CLINGEN MMDB and VAST+: tracking structural similarities between macromolecular complexes. 24319143 2014
Necrotizing encephalopathy, infantile subacute, of Leigh
0.300 Biomarker disease CLINGEN Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. 23385875 2013
Necrotizing encephalopathy, infantile subacute, of Leigh
0.300 Biomarker disease CLINGEN The novel mutation p.Asp251Asn in the β-subunit of succinate-CoA ligase causes encephalomyopathy and elevated succinylcarnitine. 23759946 2013
Necrotizing encephalopathy, infantile subacute, of Leigh
0.300 Biomarker disease CLINGEN A novel homozygous mutation in SUCLA2 gene identified by exome sequencing. 23010432 2012
Necrotizing encephalopathy, infantile subacute, of Leigh
0.300 Biomarker disease CLINGEN SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. 17301081 2007
Necrotizing encephalopathy, infantile subacute, of Leigh
0.300 Biomarker disease CLINGEN Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. 17287286 2007
Necrotizing encephalopathy, infantile subacute, of Leigh
0.300 Biomarker disease CLINGEN Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. 15877282 2005